DEF 14A

Company

Evofem Biosciences, Inc.

Filed

April 24, 2019

Period of Report

June 5, 2019

Accession Number

0001618835-19-000068

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →